Testing effectiveness (Phase 2)Ended earlyNCT03130439
What this trial is testing
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 27